| 1 |
Liu CA, Liu T, Li HC, Song MM, Ge YZ, Ruan GT, Deng L, Zhang Q, Xie HL, Lin SQ, Shi JY, Shi HP. Nutrition impact symptoms: Noteworthy prognostic indicators for lung cancer. Clin Nutr 2023;42:550-8. [PMID: 36863291 DOI: 10.1016/j.clnu.2023.02.021] [Reference Citation Analysis]
|
| 2 |
Tan S, Xu J, Wang J, Zhang Z, Li S, Yan M, Tang M, Liu H, Zhuang Q, Xi Q, Meng Q, Jiang Y, Wu G. Development and validation of a cancer cachexia risk score for digestive tract cancer patients before abdominal surgery. J Cachexia Sarcopenia Muscle 2023. [PMID: 36880286 DOI: 10.1002/jcsm.13207] [Reference Citation Analysis]
|
| 3 |
Argilés JM, López-Soriano FJ, Stemmler B, Busquets S. Cancer-associated cachexia - understanding the tumour macroenvironment and microenvironment to improve management. Nat Rev Clin Oncol 2023. [PMID: 36806788 DOI: 10.1038/s41571-023-00734-5] [Reference Citation Analysis]
|
| 4 |
Jiang X, Wang K, Wang J, Li Y, Jiang Y, Wang N, Qiao Y, Du Y, Chen R, Zhang R, Li J. A novel prognostic model of gastric cancer patients based on cachexia status by using plasma exosome-derived miRNAs.. [DOI: 10.21203/rs.3.rs-2437588/v1] [Reference Citation Analysis]
|
| 5 |
Misiewicz A, Dymicka-Piekarska V. Fashionable, but What is Their Real Clinical Usefulness? NLR, LMR, and PLR as a Promising Indicator in Colorectal Cancer Prognosis: A Systematic Review. J Inflamm Res 2023;16:69-81. [PMID: 36643953 DOI: 10.2147/JIR.S391932] [Reference Citation Analysis]
|
| 6 |
He C, Konishi R, Harata A, Nakamura Y, Mizuno R, Yoda M, Toi M, Kawaguchi K, Kawaoka S. Serum amyloid alpha 1-2 are not required for liver inflammation in the 4T1 murine breast cancer model. Front Immunol 2023;14:1097788. [PMID: 36817472 DOI: 10.3389/fimmu.2023.1097788] [Reference Citation Analysis]
|
| 7 |
Zou Y, Xu H, Cui J, Wang K, Feng Y, Shi H, Li W, Song C; Investigation on Nutrition Status and Its Clinical Outcome of Common Cancers, INSCOC Project. Association of Phase Angle with Overall Survival in Patients with Cancer: A Prospective Multicenter Cohort Study. Nutr Cancer 2023;75:890-900. [PMID: 36632984 DOI: 10.1080/01635581.2023.2165693] [Reference Citation Analysis]
|
| 8 |
Liu T, Liu C, Deng L, Song M, Lin S, Shi H. The prognostic effect of sixteen malnutrition/inflammation-based indicators on the overall survival of chemotherapy patients. Front Immunol 2023;14:1117232. [PMID: 36875131 DOI: 10.3389/fimmu.2023.1117232] [Reference Citation Analysis]
|
| 9 |
Zhang Q, Wang Z, Song M, Liu T, Ding J, Deng L, Zhang X, Qian L, Ge Y, Xie H, Ruan G, Song C, Yao Q, Xu H, Ju H, Shi H. Effects of systemic inflammation and frailty on survival in elderly cancer patients: Results from the INSCOC study. Front Immunol 2023;14:936904. [PMID: 36891320 DOI: 10.3389/fimmu.2023.936904] [Reference Citation Analysis]
|
| 10 |
Xie H, Ruan G, Wei L, Zhang H, Zhang Q, Ge Y, Lin S, Song M, Zhang X, Liu X, Zhang X, Li X, Zhang K, Yang M, Tang M, Deng L, Shi H. A novel inflammation-nutrition biomarker score for predicting prognosis of patients with cancer: results from a multicenter study. BMC Cancer 2022;22:1311. [DOI: 10.1186/s12885-022-10399-5] [Reference Citation Analysis]
|
| 11 |
Lyu J, Yang N, Guan W, Xiao L, Nie X, Liang L, Bai H, Li C, Kuang H, Wang X, Li T. Post-treatment serum triglyceride: An effective biomarker for body fat mass and overall survival in esophageal squamous cell cancer patients treated with chemoradiotherapy. Front Nutr 2022;9. [DOI: 10.3389/fnut.2022.1050643] [Reference Citation Analysis]
|
| 12 |
Eggelbusch M, Shi A, Broeksma BC, Vázquez-Cruz M, Soares MN, de Wit GMJ, Everts B, Jaspers RT, Wüst RCI. The NLRP3 inflammasome contributes to inflammation-induced morphological and metabolic alterations in skeletal muscle. J Cachexia Sarcopenia Muscle 2022;13:3048-61. [PMID: 35978267 DOI: 10.1002/jcsm.13062] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 13 |
Fröhlich AK, Diek M, von Haehling S, Anker MS. Furnishing the cachexia landscape: A year of research in JCSM. J Cachexia Sarcopenia Muscle 2022;13:2763-71. [PMID: 36510825 DOI: 10.1002/jcsm.13151] [Reference Citation Analysis]
|
| 14 |
Wang Y, An Z, Lin D, Jin W. Targeting cancer cachexia: Molecular mechanisms and clinical study. MedComm 2022;3. [DOI: 10.1002/mco2.164] [Reference Citation Analysis]
|
| 15 |
Clamon G, Byrne MM, Talbert EE. Inflammation as a Therapeutic Target in Cancer Cachexia. Cancers (Basel) 2022;14. [PMID: 36358681 DOI: 10.3390/cancers14215262] [Reference Citation Analysis]
|
| 16 |
Zhang HY, Xie HL, Ruan GT, Zhang Q, Ge YZ, Liu XY, Tang M, Song MM, Lin SQ, Yang M, Zhang XW, Xu HX, Song CH, Shi HP. Lymphocyte to C-reactive protein ratio could better predict the prognosis of patients with stage IV cancer. BMC Cancer 2022;22:1080. [PMID: 36266627 DOI: 10.1186/s12885-022-10145-x] [Reference Citation Analysis]
|
| 17 |
He C, Konishi R, Harata A, Nakamura Y, Mizuno R, Yoda M, Toi M, Kawaguchi K, Kawaoka S. Serum amyloid alpha 1-2 are not required for systemic inflammation in the 4T1 murine breast cancer model.. [DOI: 10.1101/2022.09.26.509617] [Reference Citation Analysis]
|
| 18 |
Fan S, Xie X, Shen Y, Wang W, Gu X, Yao Z. The predictive value of preoperative serum neutrophil-to-lymphocyte ratio and tumor markers for early breast cancer patients: A retrospective study. Medicine (Baltimore) 2022;101:e30011. [PMID: 35960055 DOI: 10.1097/MD.0000000000030011] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 19 |
Liu C, Zhang Q, Ruan G, Shen L, Xie H, Liu T, Tang M, Zhang X, Yang M, Hu C, Zhang K, Liu X, Shi H. Novel Diagnostic and Prognostic Tools for Lung Cancer Cachexia: Based on Nutritional and Inflammatory Status. Front Oncol 2022;12:890745. [DOI: 10.3389/fonc.2022.890745] [Reference Citation Analysis]
|
| 20 |
Huang Y, Lin Y, Zhai X, Cheng L. Association of Beta-2-Microglobulin With Coronary Heart Disease and All-Cause Mortality in the United States General Population. Front Cardiovasc Med 2022;9:834150. [DOI: 10.3389/fcvm.2022.834150] [Reference Citation Analysis]
|
| 21 |
Ge YZ, Ruan GT, Zhang Q, Dong WJ, Zhang X, Song MM, Zhang XW, Li XR, Zhang KP, Tang M, Li W, Shen X, Shi HP; Investigation on the Nutrition Status and Clinical Outcome of Common Cancers (INSCOC) Group. Extracellular water to total body water ratio predicts survival in cancer patients with sarcopenia: a multi-center cohort study. Nutr Metab (Lond) 2022;19:34. [PMID: 35525966 DOI: 10.1186/s12986-022-00667-3] [Reference Citation Analysis]
|
| 22 |
Zhao R, Liang Z, Chen K, Zhu X. Nomogram Based on Inflammatory Biomarkers and Nutritional Indicators for Predicting Overall Survival in Locoregionally Advanced Nasopharyngeal Carcinoma. JIR 2022;Volume 15:2971-81. [DOI: 10.2147/jir.s366299] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 23 |
Chakedis JM, Dillhoff ME, Schmidt CR, Rajasekera PV, Evans DC, Williams TM, Guttridge DC, Talbert EE. Identification of circulating plasma ceramides as a potential sexually dimorphic biomarker of pancreatic cancer-induced cachexia. JCSM Rapid Commun 2022;5:254-65. [PMID: 36591536 DOI: 10.1002/rco2.68] [Reference Citation Analysis]
|
| 24 |
Wang X, Zhang C, Cao F, Wang CB, Dong JN, Wang ZH. Nomogram of Combining CT-Based Body Composition Analyses and Prognostic Inflammation Score: Prediction of Survival in Advanced Epithelial Ovarian Cancer Patients. Acad Radiol 2021:S1076-6332(21)00539-0. [PMID: 34955366 DOI: 10.1016/j.acra.2021.11.011] [Reference Citation Analysis]
|
| 25 |
Wang X, Yang M, Ge Y, Tang M, Rao B, Chen Y, Xu H, Cong M, Guo Z, Shi H. Association of Systemic Inflammation and Malnutrition With Survival in Nasopharyngeal Carcinoma Undergoing Chemoradiotherapy: Results From a Multicenter Cohort Study. Front Oncol 2021;11:766398. [PMID: 34765561 DOI: 10.3389/fonc.2021.766398] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
